Target Healthcare Reit Stock EBITDA
| THRL Stock | 84.30 0.40 0.48% |
Target Healthcare REIT fundamentals help investors to digest information that contributes to Target Healthcare's financial success or failures. It also enables traders to predict the movement of Target Stock. The fundamental analysis module provides a way to measure Target Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Target Healthcare stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 58 M | 60.9 M |
Target | EBITDA |
Target Healthcare REIT Company EBITDA Analysis
Target Healthcare's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Target Healthcare EBITDA | 58 M |
Most of Target Healthcare's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Target Healthcare REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Target Ebitda
Ebitda |
|
According to the company disclosure, Target Healthcare REIT reported earnings before interest,tax, depreciation and amortization of 58 M. This is 92.19% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The ebitda for all United Kingdom stocks is 98.51% higher than that of the company.
Target EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Target Healthcare's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Target Healthcare could also be used in its relative valuation, which is a method of valuing Target Healthcare by comparing valuation metrics of similar companies.Target Healthcare is currently under evaluation in ebitda category among its peers.
Target Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0387 | ||||
| Profit Margin | 1.05 % | ||||
| Operating Margin | 0.83 % | ||||
| Current Valuation | 724.65 M | ||||
| Shares Outstanding | 620.24 M | ||||
| Shares Owned By Insiders | 0.07 % | ||||
| Shares Owned By Institutions | 73.24 % | ||||
| Price To Book | 0.76 X | ||||
| Price To Sales | 6.66 X | ||||
| Revenue | 78.48 M | ||||
| Gross Profit | 60.32 M | ||||
| EBITDA | 58 M | ||||
| Net Income | 73.02 M | ||||
| Total Debt | 240.67 M | ||||
| Book Value Per Share | 1.11 X | ||||
| Cash Flow From Operations | 42.34 M | ||||
| Earnings Per Share | 0.12 X | ||||
| Target Price | 105.0 | ||||
| Beta | 0.43 | ||||
| Market Capitalization | 522.86 M | ||||
| Total Asset | 967.37 M | ||||
| Retained Earnings | 176.7 M | ||||
| Annual Yield | 0.07 % | ||||
| Net Asset | 967.37 M | ||||
| Last Dividend Paid | 0.057 |
About Target Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Target Healthcare REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Target Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Target Healthcare REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Target Stock Analysis
When running Target Healthcare's price analysis, check to measure Target Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Target Healthcare is operating at the current time. Most of Target Healthcare's value examination focuses on studying past and present price action to predict the probability of Target Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Target Healthcare's price. Additionally, you may evaluate how the addition of Target Healthcare to your portfolios can decrease your overall portfolio volatility.